Brief: Mayne Pharma Group Signs Licence Agreement For Blissel In Australia
15/09/2026 03:04
BRIEF-Mayne Pharma Group Signs Licence Agreement For Blissel In Australia Sept 15 (Reuters) - Mayne Pharma Group Ltd MYX.AX:
MYX SIGNS LICENCE AGREEMENT FOR BLISSEL IN AUSTRALIA
SIGNS EXCLUSIVE FIVE-YEAR LICENCE AGREEMENT WITH ITALFARMACO S.A FOR BLISSEL IN AUSTRALIA
Further company coverage: MYX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)